Atropine, 0.01%, for Myopia Control

JAMA Ophthalmol. 2023 Aug 1;141(8):766-767. doi: 10.1001/jamaophthalmol.2023.3076.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Atropine* / therapeutic use
  • Disease Progression
  • Humans
  • Mydriatics
  • Myopia* / prevention & control
  • Ophthalmic Solutions
  • Refraction, Ocular

Substances

  • Atropine
  • Mydriatics
  • Ophthalmic Solutions